This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant...

Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients with mild to moderate renal...

India's first homegrown antibiotic, Nafithromycin, targets drug-resistant pneumonia and marks a milestone in the country's battle against...

A multicenter Phase II clinical trial led by researchers at The University of Texas MD Anderson Cancer Center demonstrated significant tumor shrinkage...

Data presented at IDWeek 2025 after study stopped early for efficacy Primary endpoint met, demonstrating non-inferiority of oral tebipenem HBr...

Results from the phase 2 (dose optimization) part of the REJOICE─Ovarian01 phase 2/3 trial showed that raludotatug deruxtecan (R─DXd) demonstrated...

Breast cancer is the most common cancer among women worldwide (WHO, 2023). The Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP),...

Ethiopia has taken a major step forward in the fight against tuberculosis (TB) by launching a national AI-powered digital X-ray system for TB...

Researchers from UCLA have found a promising new way to help men with recurring prostate cancer live longer without their disease getting worse. In a...